Patients interested in medical weight loss should speak with a licensed provider about currently available options, including tirzepatide and semaglutide when clinically appropriate
A patient who wants to relieve obstructive sleep apnea and eliminate their CPAP machine may require a 10% or 15% weight loss
According to NICE technology appraisal guidance (TA875) , semaglutide for weight management is recommended for adults with a BMI of 35 kg/m or greater, or 32.5 kg/m or greater for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds
What the dual GLP-1/GIP data means for buyers right now
Mounjaro Another popular weight loss injection is Mounjaro (active ingredient tirzepatide)
Future research is expected to clarify the role of GLP-1 receptor agonists in the management of pediatric obesity